No linkage or linkage disequilibrium between brain-derived neurotrophic factor (BDNF) dinucleotide repeat polymorphism and schizophrenia in Irish families

Psychiatry Research

Volumn 81, Issue 2, 1998, Pages 111-116

  Hawi, Ziarih ^a   Straub, Richard E ^b   O'Neill, Anthony ^c   Kendler, Kenneth S ^b   Walsh, Dermot ^d   Gill, Michael ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d HEALTH RESEARCH BOARD   (Ireland)

Author keywords

Association; BDNF; Brain derived neurotrophic factor; Linkage; Schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DINUCLEOTIDE; DNA;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; DNA POLYMORPHISM; FAMILY STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC LINKAGE; GENETIC PREDISPOSITION; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 17144446667     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(98)00076-6     Document Type: Article

References (23)

1. Bogerts B. Recent advances in the neuropathology of schizophrenia. Schizophrenia Bulletin. 19(2):1993;431-445.
2. Bracha H.S., Torrey E.F., Karson C.N., Bigelow L.B. A twin study of prenatal injury markers in psychosis: timing the insult. Schizophrenia Research. 4:1991;250.
3. Eaton M.J., Staley J.K., Globus M.Y., Whittemore S.R. Developmental regulation of early serotonergic neuronal differentiation. The role of brain-derived neurotrophic factor and membrane depolarization. Developmental Biology. 170:1995;169-182.
4. Gill M., Hawi Z., Straub R.E., O'Neill F.A., Walsh D., Kendler K. Neurotrophin-3 gene polymorphisms and schizophrenia: no evidence for linkage or association. Psychiatric Genetics. 6:1996;183-186.
5. p14. Genomics. 13:1992;1331-1333.
6. Hofer M.M., Barde Y.A. Brain derived neurotrophic factor prevents neuronal death in vivo. Nature. 331:1988;261-262.
7. Ikeda K., Klinkosz B., Greene T., Cedarbaum J.M., Wong V., Lindsay R.M., Mitsumoto H. Effect of brain derived-neurotrophic factor on motor disfunction in wobbler mouse motor neuron disease. American Journal of Neurology. 37(4):1995;505-511.
8. Jacobson N., Daniels J., Moorhead S., Harrison D., Feldman E., McGuffin P., Owen M.J., Craddock N. Association study of bipolar disorder at the phospholipase A2 gene (PLA2A) in the Darier's disease (DAR) region of chromosome 12q23-q24.1. Psychiatric Genetics. 6:1996;195-199.
9. Jakob H., Beckmann H. Prenatal development disturbances in the limbic allocortex in schizophrenics. Journal of Neural Transmission. 65:1986;303-326.
10. Jones E.R., Richard L.F. Molecular cloning of human gene that is a member of gene growth factor family. Proceedings of the National Academy of Sciences of the United States of America. 87:1990;8060-8064.
11. Kendler K.S., O'Neill F.A., Murphy B., Duke F., Straub R.E., Shinkwin R., Ninualliain M., MacLean C.J., Walsh D. The Irish study of high density schizophrenia families: field methods and power to detect linkage. American Journal of Medical Genetics (Neuropsychiatric Genetics). 57:1996;179-190.
12. Lim L.C., Powell J., Sham P., Castle D., Hunt N., Murray R., Gill M. Evidence for a genetic association between alleles of monoamine oxidase A gene and bipolar affective disorder. American Journal of Medical Genetics (Neuropsychiatric Genetics). 60:1995;325-331.
13. Proschel M., Saunders A., Roses A.D., Muller C.R. Dinucleotide repeat polymorphism at human gene for brain derived neurotrophic factor (BDNF). Human Molecular Genetics. 1(5):1992;535.
14. Rosier M.F., Goguel A.F., Martin A., Le Paslier D., Couillin P., Houlgatte R., Bernheim A., Auffray C., Devignes M.D. A 1.7-Mb YAC contig around the human BDNF gene (11p13): integration of the physical, genetic, and cytogenetic maps in relation to WAGR syndrome. Genomics. 24:1994;69-77.
15. Sasaki T., Dai X.-Y., Kuwata S., Fukuda R., Kunugi H., Hattori M., Nanko S. Brain-derived neurotrophic factor gene and schizophrenia in Japanese subjects. American Journal of Medical Genetics (Neuropsychiatric Genetics). 74:1997;443-444.
16. Seroogy K.B., Lundgren K.H., Tran T.M., Guthrie K.M., Isackson P.J., Gall C.M. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. Journal of Comprehensive Neurology. 342:1994;321-334.
17. Sham P.C., Curtis D. An extended transmission/disequilibrium test (TDT) for multi-allele marker loci. Annals of Human Genetics. 59:1995;323-336.
18. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission test for linkage disequilibrium: the insulin gene region and insulin diabetes mellitus (IDDM). American Journal of Human Genetics. 52(3):1993;505-516.
19. Straub R.E., MacLean C.J., O'Neil F.A., Burke J., Murphy B., Duke F., Shinkwin R., Webb B.J., Zhang J., Walsh D., Kendler K.S. A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for heterogeneity. Nature Genetics. 11:1995;287-293.
20. Studer L., Spenger C., Seiler R.W., Altar C.A., Lindsay R.M., Hyman C. Comparison of effect of the neurotrophins of the morphological structure of dopaminergic neurones in cultures of rat substantia nigra. European Journal of Neuroscience. 7:1995;223-233.
21. Suddath R.L., Casanova M.F., Goldberg T.E., Daniel D.G., Kelsoe J.R., Weinberg D.R. Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study. American Journal of Psychiatry. 146(4):1989;464-472.
22. Weinburger D.R. From neuropathology to neurodevelopment. Lancet. 346:1995;552-557.
23. Zhou J., Bradford H.F., Stern G.M. The stipulatory effect of brain derived neurotrophic factor on dopaminergic phenotype expression of embryonic rat cortical neurons in vitro. Developmental Brain Research. 81:1994;318-324.